Morgan Stanley Upgrades UNH Ahead of Earnings on Margin and AI Upside
TL;DR
Morgan Stanley upgrades UnitedHealth (UNH) to Top Pick ahead of its Q1 results, citing clearer Medicare Advantage rate guidance, ongoing MA margin improvement, an Optum Health turnaround, and potential AI-driven efficiencies. A Q1 miss or beat is expected to be largely in line with expectations, with analysts eyeing tangible margin gains in 2027–2028 and a stronger stock trajectory if results align. The firm’s price target is $375 amid a broader Street consensus of Strong Buy with roughly 13% 12‑month upside.
- ‘Scoop Up,’ Says Morgan Stanley on UnitedHealth Stock (UNH) Ahead of Earnings TipRanks
- UnitedHealth tops quarterly estimates, hikes profit outlook as insurer manages high medical costs CNBC
- UnitedHealth Tops Views, Leads Dow Jones Amid Lower Health Costs Investor's Business Daily
- UnitedHealth Shows Signs of Turnaround With Strong Quarterly Results WSJ
- UnitedHealth’s stock surges as profit beats expectations by widest margin in five years MarketWatch
Want the full story? Read the original reporting
Read on TipRanks